MOTS-c is a mitochondrial peptide that combats aging and metabolic stress. It is encoded by the mitochondrial 12S rRNA gene, which is part of the mitochondrial DNA and the mitochondrial genome. The mitochondrial genome contains mitochondrial open reading frames (ORFs) that encode peptides like MOTS-c. It mimics exercise, enhancing metabolism and insulin sensitivity while reducing inflammation.
As a mitochondrial-derived peptide, MOTS-c is an encoded peptide MOTS-c, specifically a mitochondrial encoded peptide MOTS, and is one of several peptides derived from mitochondrial ORFs. This article examines MOTS-c’s benefits and health potential.
Introduction to MOTS-c
MOTS-c, known as a mitochondrial-derived peptide, is a 16-amino acid molecule encoded by the mitochondrial 12S rRNA gene. As a derived peptide mots c, it plays a pivotal role in maintaining metabolic homeostasis by regulating key processes such as insulin resistance and glucose metabolism. Unlike many peptides that originate from nuclear DNA, MOTS-c is unique in that it is a mitochondrial derived peptide, highlighting the emerging importance of mitochondrially derived peptides in cellular health.
One of the primary sites of MOTS-c action is skeletal muscle, where it enhances insulin sensitivity and promotes efficient glucose uptake. This function is crucial for supporting energy production and preventing metabolic dysfunction, especially under conditions of metabolic stress. MOTS-c also exerts its effects by regulating nuclear gene expression, allowing cells to adapt to changing metabolic demands and maintain balance.
The ability of mitochondrial derived peptide mots to influence both mitochondrial and nuclear processes positions MOTS-c as a key player in the body’s response to metabolic challenges. Its involvement in improving insulin sensitivity and glucose metabolism has made it a promising candidate for therapeutic interventions targeting diabetes, obesity, and age-related diseases. As research continues to uncover the molecular mechanisms of this amino acid peptide, MOTS-c stands out as a significant focus in the quest to understand and enhance metabolic health.
Key Takeaways
- MOTS-c is a mitochondrial peptide that enhances metabolic health by activating key pathways like AMPK, improving insulin sensitivity, and regulating glucose and lipid metabolism.
- Research suggests MOTS-c has potential therapeutic applications for obesity, insulin resistance, neurodegenerative diseases, and chronic fatigue by enhancing cellular resilience and promoting metabolic balance.
- Current challenges in MOTS-c research include understanding its molecular mechanisms and gene interactions, which are critical for developing effective therapeutic strategies and ensuring clinical safety.
Understanding MOTS-c Peptide
MOTS-c, a mitochondrial encoded mots peptide, is a small but mighty molecule derived peptide mots c from the 12S rRNA gene within the mitochondria. This 16 amino acid peptide is a member of a unique class of mitochondrial derived peptides and mitochondrial peptides, which play crucial roles in cellular function and homeostasis. Research suggests that endogenous mots c peptide mots c promotes MOTS-c functions as an exercise mimetic, imitating the beneficial effects of physical activity on the body, while also influencing endogenous mots c levels. MOTS-c is considered an exercise induced mitochondrial encoded peptide, as its expression is stimulated by physical activity.
One of the significant roles of MOTS-c is its involvement in activating key molecules such as AMP-activated protein kinase (AMPK), SIRT1, and NF-kB, which are associated with improved metabolic functions and anti-inflammatory effects. MOTS-c maintains metabolic flexibility and homeostasis by activating these molecules, playing a crucial role in the body’s response to metabolic stress.
Beyond metabolic regulation, MOTS-c influences adaptive nuclear gene expression by regulating stress adaptation-related nuclear genes to regulate nuclear gene expression, impacting cellular metabolism and resilience. This regulation positions MOTS-c as a key defender against metabolic disturbances.
What makes MOTS-c particularly fascinating is its dual role in both mitochondria and the nucleus. It not only acts within the mitochondria to influence mitochondrial energy production and metabolic processes but also moves into the nucleus to modulate gene expression, thereby exerting systemic effects. MOTS-c acts as an induced mitochondrial encoded regulator, adapting cellular responses to metabolic stress and exercise. This dual functionality underscores the peptide’s potential as a powerful tool in combating metabolic dysregulation and aging.
While exploring MOTS-c’s functions and benefits, it’s important to note that current insights are based on animal studies and should not be directly extrapolated to humans. The research conducted so far provides a promising glimpse into the potential applications of this remarkable peptide, setting the stage for future explorations.
The Role of MOTS-c in Metabolic Homeostasis
MOTS-c plays a pivotal role in regulating metabolic homeostasis, a state of balance in the body’s metabolic processes. This balance is crucial for maintaining overall health and preventing metabolic disorders. The peptide’s ability to activate AMPK is one of the key mechanisms through which it achieves this balance. AMPK, often referred to as the body’s energy sensor, helps regulate energy expenditure and enhances insulin sensitivity, which is vital for metabolic health.
One of the remarkable aspects of MOTS-c is its role in glucose metabolism. Research suggests that MOTS-c acts as a ‘motion simulator,’ enhancing insulin sensitivity and improving glucose metabolism. This effect is particularly significant in skeletal muscle, where MOTS-c influences processes that inhibit insulin resistance. MOTS-c maintains metabolic homeostasis and glucose homeostasis, preventing dysfunction by enhancing glucose conversion into energy.
MOTS-c’s impact on insulin sensitivity is further supported by its anti-inflammatory properties. Studies indicate that MOTS-c can reduce insulin resistance by mitigating inflammation, which is often a contributing factor to metabolic disorders. This dual action of improving glucose metabolism and reducing inflammation positions MOTS-c as a potential therapeutic agent for managing metabolic stress.
The peptide’s influence on metabolic balance extends beyond glucose metabolism. It also affects lipid metabolism and energy expenditure, contributing to overall metabolic health. MOTS-c enhances mitochondrial fatty acid oxidation, supporting efficient energy production and metabolic flexibility. By activating multiple signaling pathways, including those involving AMPK and SIRT1, MOTS-c enhances insulin sensitivity and promotes metabolic flexibility. This ability to regulate multiple aspects of metabolism underscores the peptide’s potential in addressing metabolic dysfunction.
Furthermore, MOTS-c’s role in skeletal muscle metabolism is particularly noteworthy. The primary target organ for MOTS-c’s action is skeletal muscle, where it enhances glucose utilization and inhibits insulin resistance. This focus on skeletal muscle highlights the peptide’s potential in improving physical performance and combating metabolic stress.
MOTS-c’s role in metabolic homeostasis involves regulate metabolic homeostasis, glucose and lipid metabolism, insulin sensitivity, and anti-inflammatory responses. Its ability to activate key molecules and signaling pathways makes it a promising candidate for further research into cell metab, metabolic health, and disease prevention.
Research on MOTS-c and Insulin Resistance
Insulin resistance is crucial in developing metabolic disorders like type 2 diabetes metab and metabolic syndrome. Research on MOTS-c shows promise in enhancing insulin sensitivity and reducing insulin resistance, particularly in skeletal muscle, suggesting its potential to attenuate insulin resistance as a therapeutic agent for obesity and insulin resistance.
In aged male mice, MOTS-c administration has been shown to restore insulin sensitivity to levels comparable to those of younger mice after a short treatment period. This finding suggests that MOTS-c could address age-related declines in metabolic function, often linked to increased insulin resistance and dysfunction.
Further studies indicate that MOTS-c can mitigate insulin resistance caused by high-fat diets in animal models. High-fat diets are known to induce metabolic stress and insulin resistance, leading to obesity and related metabolic disorders. By improving insulin sensitivity and lowering glucose levels, MOTS-c demonstrates potential in managing diabetes and metabolic syndrome.
Enhancing glucose uptake and improving insulin signaling in skeletal muscle are key mechanisms of MOTS-c’s effects on insulin resistance. By activating pathways like AMPK, MOTS-c promotes glucose metabolism to enhance glucose metabolism and mitigates the negative impact of metabolic stress on insulin sensitivity, making it a promising candidate for further research.
Overall, the research on MOTS-c and insulin resistance provides valuable insights into the peptide’s potential applications in managing metabolic disorders. While these findings are based on animal studies, they offer a promising foundation for future research aimed at developing effective strategies for combating insulin resistance and related conditions.
MOTS-c’s Impact on Obesity
Obesity represents a growing concern in laboratory research settings, frequently associated with metabolic alterations such as insulin resistance and diabetes in experimental models. Research suggests that MOTS-c may potentially influence metabolic processes in laboratory settings by enhancing energy expenditure. Fascinating findings from recent studies indicate that MOTS-c administration reduces obesity markers and has been observed to prevent diet-induced insulin resistance in animal models. Laboratory investigations using mouse skeletal muscle have demonstrated that exposure to this peptide corresponds with improved insulin sensitivity and metabolic function in these research specimens.
In experimental models where mice were administered high-fat diets, laboratory data indicates that MOTS-c administration resulted in noteworthy reductions in body weight and enhanced insulin sensitivity compared to control subjects maintained on standard laboratory nutrition. This observed effect appears to be connected to the peptide’s capacity to enhance glucose utilization in skeletal muscle tissue of these research subjects, thereby potentially reducing the accumulation of excess fatty acids and promoting metabolic equilibrium in these controlled research environments.
Research suggests MOTS-c’s impact on obesity extends beyond glucose metabolism in laboratory settings. The peptide has been observed to elevate energy expenditure and enhance lipid oxidation in research models, which represent crucial factors when examining diet-induced obesity in controlled studies. By promoting the breakdown of lipids and increasing energy utilization in research specimens, MOTS-c shows promising research applications for reducing fat accumulation and supporting metabolic homeostasis in laboratory conditions.
Another notable aspect emerging from recent studies involves MOTS-c’s ability to regulate fat metabolism in research models. Laboratory investigations indicate that MOTS-c administration enhances lipid oxidation and decreases fat accumulation in mice subjected to high-fat nutritional protocols in controlled settings. This dual mechanism of reducing fat storage while simultaneously increasing fat utilization underscores the compound’s potential significance in research focusing on metabolic disorders within laboratory environments.
Research suggests MOTS-c’s impact on obesity includes regulation of glucose and lipid metabolism, energy expenditure, and insulin sensitivity in experimental models. The peptide’s observed capacity to enhance metabolic processes and influence diet-induced obesity in laboratory settings highlights its potential as a research substance for scientific investigations into metabolic function. These findings contribute valuable insights to our understanding of metabolic regulation in research contexts, though further laboratory studies are necessary to fully elucidate the mechanisms involved.
Age-Related Decline and MOTS-c
Laboratory studies indicate that aging is frequently accompanied by alterations in metabolic function and physical performance metrics, including age-dependent physical changes in experimental models. Current research suggests that MOTS-c levels demonstrate an inverse relationship with aging processes, with detectable decreases in tissue samples such as skeletal muscle as the research subjects age. This observed reduction in MOTS-c expression appears to correlate with diminished metabolic flexibility and heightened susceptibility to metabolic stress, particularly within the cellular environment of aging specimens.
Intriguingly, laboratory investigations have demonstrated that stress conditions and exercise protocols appear to activate MOTS-c expression in research models, potentially contributing to improved functional metabolism and physical performance metrics. These findings suggest that this fascinating compound may play a significant role in adaptive responses to metabolic challenges, potentially contributing to homeostatic balance and resilience in experimental settings.
In controlled studies with murine models, late-life administration of the MOTS-c compound has been observed to correlate with enhanced grip strength measurements, improved gait parameters (stride length), and overall physical performance metrics. These documented improvements in functional assessments highlight the compound’s potential research applications regarding age-related processes. The scientific community continues to investigate these promising observations in various laboratory models.
Moreover, multiple investigations indicate that MOTS-c administration significantly correlates with improved physical function in murine subjects across various age groups, suggesting potential avenues for further research into metabolic regulation. By potentially enhancing metabolic processes and contributing to metabolic homeostasis in laboratory settings, this compound presents interesting possibilities for continued scientific exploration of biological aging mechanisms.
In conclusion, the observed relationship between aging processes and MOTS-c levels in research models highlights intriguing research directions. The compound’s apparent capacity to influence metabolic flexibility and physical performance metrics in laboratory settings offers promising avenues for continued scientific investigation. Research examining circulating MOTS-c levels may contribute valuable insights to our understanding of fundamental biological processes, furthering our knowledge of cellular and systemic metabolism in experimental contexts.
Molecular Mechanisms of MOTS-c
Understanding the molecular mechanisms underlying MOTS-c’s effects is crucial for unlocking its full potential. Research suggests stress and exercise primarily trigger MOTS-c, leading to its movement into the nucleus to influence gene expression. This regulation is key to maintaining metabolic balance and resilience.
In response to cellular stress, MOTS-c can reach the nucleus within 30 minutes and return within a day. This rapid movement highlights the peptide’s role in adapting to metabolic challenges, regulating processes, and maintaining homeostasis by influencing gene expression.
One of the key pathways activated by MOTS-c is the AMPK pathway, which is associated with enhanced glucose uptake and fat oxidation. By activating AMPK, MOTS-c promotes energy expenditure and improves insulin sensitivity, thereby supporting metabolic health. MOTS-c interacts synergistically with key metabolic pathways, such as AMPK and PGC-1α, to enhance metabolic regulation and promote mitochondrial function.
MOTS-c’s impact on metabolic processes extends to its ability to improve insulin signaling and facilitate better glucose metabolism in skeletal muscle. This effect is particularly significant in the context of metabolic disorders, where impaired insulin signaling is a common issue.
Furthermore, MOTS-c modulates mitochondrial gene expression by interacting with several transcription factors, including NRF2. This transcription factor interaction helps coordinate the body’s response to metabolic stress and maintain metabolic balance. However, there is still insufficient research summarizing the specific genes and pathways influenced by MOTS-c, presenting a gap in understanding its physiological effects.
In summary, MOTS-c’s molecular mechanisms involve its dynamic movement to the nucleus, activation of key pathways like AMPK, and modulation of gene expression. Recent studies published in Nucleic Acids Res have contributed to understanding the molecular mechanisms of MOTS-c in aging and metabolism. Understanding these mechanisms is essential for exploring the peptide’s full therapeutic potential and addressing metabolic disorders.
Exercise and MOTS-c
Exercise is a powerful stimulus for the expression of MOTS-c, with studies showing that physical activity increases circulating levels of this mitochondrial-derived peptide in humans. When skeletal muscle contracts during exercise, it releases MOTS-c, which then acts on various tissues to help regulate metabolic homeostasis. This process is particularly important for improving insulin sensitivity and supporting healthy glucose metabolism.
MOTS-c treatment has been shown to reduce insulin resistance and enhance glucose uptake in muscle cells, making it a promising approach for managing conditions like type 2 diabetes. By boosting insulin sensitivity in skeletal muscle, MOTS-c helps the body use glucose more efficiently, which is essential for maintaining stable blood sugar levels and preventing metabolic dysfunction.
Beyond its immediate metabolic effects, exercise-induced MOTS-c expression is linked to improved mitochondrial function and increased mitochondrial biogenesis. These adaptations are vital for sustaining energy production and combating age dependent physical decline. Enhanced mitochondrial function not only supports better physical performance but also helps protect against the onset of chronic diseases associated with aging.
The relationship between exercise and MOTS-c underscores the importance of regular physical activity in promoting metabolic health. By increasing mots c expression, exercise helps maintain muscle homeostasis, reduce insulin resistance, and support overall physical performance. This synergy between exercise and MOTS-c highlights a natural and effective strategy for preventing metabolic disorders and supporting healthy aging.
MOTS-c and Muscle Homeostasis
Maintaining muscle homeostasis is crucial for overall physical health, especially with aging. Research on MOTS-c shows that this mitochondrial-derived peptide significantly promotes muscle health during metabolic stress, increasing endurance and performance metrics in older mice compared to untreated controls. Notably, MOTS-c supports metabolic function and performance across various skeletal muscles, not just a single muscle group.
Late-life MOTS-c treatment significantly enhances physical performance in older mice, suggesting its potential in mitigating age-related decline. These improvements highlight the peptide’s role in promoting muscle health and maintaining performance.
The expression of MOTS-c in the body is influenced by regular exercise, which also elevates mitochondrial activity. Increased MOTS-c expression through exercise is linked to better physical function and performance outcomes, underscoring the importance of physical activity in maintaining muscle cells health.
Regular physical activity increases MOTS-c levels in skeletal muscle, supporting its role in promoting muscle homeostasis. This relationship highlights the peptide’s potential in enhancing physical performance and resilience.
Moreover, MOTS-c acts as a signaling molecule that helps coordinate muscle and bone metabolism, emphasizing its role in maintaining musculoskeletal health. By promoting muscle health and enhancing metabolic processes, mots c promotes metabolic health, helping maintain physical performance and prevent age-related decline.
MOTS-c’s role in muscle homeostasis involves enhancing physical performance, exercise influence on its expression, and coordination of muscle and bone metabolism. These findings highlight the peptide’s potential in promoting muscle health and maintaining overall physical performance.
Potential Therapeutic Applications
Laboratory investigations into MOTS-c suggest numerous potential research applications, considering its multifaceted role in metabolic regulation and physical performance metrics. Research suggests that the exploration of MOTS-c in muscle performance and health represents a promising avenue of scientific inquiry. Studies indicate that through its enhancement of metabolic processes and promotion of muscle homeostasis in experimental models, MOTS-c could potentially serve as a valuable subject for investigating conditions related to muscular function and performance parameters in controlled laboratory settings.
Preliminary research findings indicate that MOTS-c may exhibit neuroprotective properties in cellular models, potentially warranting further investigation in research concerning neurological cellular resilience. The compound’s apparent ability to enhance mitochondrial function and modulate inflammatory responses in laboratory settings suggests it merits examination in cellular studies where mitochondrial dysfunction and inflammatory cascades are observed phenomena.
In experimental models exhibiting energy production deficiencies, research suggests MOTS-c might influence cellular ATP production and address mitochondrial inefficiencies. This research direction highlights the peptide’s apparent role in cellular energy metabolism regulation and fatigue-related biochemical pathways, which represent critical factors in understanding metabolic dysfunction at the cellular level.
Studies indicate that MOTS-c appears to influence pro-inflammatory and anti-inflammatory cytokine expression through modulation of reactive oxygen species (ROS) levels. This observed modulation in laboratory settings suggests potential for cardiovascular research applications through its apparent enhancement of mitochondrial function and influence on metabolic markers associated with cellular health in experimental models.
Laboratory investigations suggest MOTS-c may warrant examination in cancer research contexts through its observed ability to influence cellular proliferation via improved metabolic balance in experimental models. Research indicates that the enhancement of metabolic processes and reduction of inflammatory markers in controlled studies might offer insights into cellular growth regulation and overall metabolic function in research settings.
The potential research applications of MOTS-c include:
- Investigating muscle performance in laboratory models
- Examining cellular neuroprotective mechanisms
- Studying cellular energy production pathways
- Researching cardiovascular cellular function
These preliminary findings underscore the compound’s versatility in research contexts and suggest multiple avenues for further scientific investigation in controlled laboratory settings.
Current Challenges and Future Directions
Despite the promising research on MOTS-c, there are several challenges that need to be addressed for its full therapeutic potential to be realized. One significant challenge is the unclear mechanism of how MOTS-c mRNA translocates from the mitochondria, which impedes further understanding of its functions. This gap in knowledge hinders the exploration of the peptide’s full range of effects and applications.
MOTS-c research faces challenges that need addressing, including more comprehensive studies to understand the specific genes and pathways influenced by MOTS-c. Overcoming these is critical for exploring MOTS-c’s therapeutic applications in treating aging and metabolic dysfunctions.
Future research should focus on elucidating the molecular pathways and mechanisms underlying MOTS-c’s action. A deeper understanding of these mechanisms will enable the development of more targeted and effective therapeutic strategies.
Another important future research area is assessing the clinical viability of MOTS-c for treating metabolic diseases following comprehensive safety evaluations. Ensuring its safety and efficacy is crucial for potential clinical applications.
In conclusion, addressing current challenges and focusing on future research is essential for unlocking MOTS-c’s full therapeutic potential. Overcoming these obstacles can pave the way for innovative treatments for aging and metabolic disorders.
Summary
In summary, MOTS-c is a remarkable mitochondrial peptide with significant potential in combating aging and metabolic stress. Its role in regulating metabolic homeostasis, enhancing insulin sensitivity, and promoting muscle health underscores its importance in maintaining overall health. The peptide’s ability to influence gene expression and modulate metabolic processes makes it a promising candidate for further research and therapeutic applications.
As we look to the future, continued research on MOTS-c will be crucial for understanding its full range of effects and applications. By addressing current challenges and exploring new research directions, we can unlock the potential of MOTS-c in promoting healthy aging and improving metabolic health. Stay tuned for more exciting developments in this fascinating field.
Frequently Asked Questions
What is MOTS-c and where is it encoded?
MOTS-c is a mitochondrial encoded peptide derived from the 12S rRNA gene, consisting of 16 amino acids, and it is essential for metabolic regulation and stress response.
Mutant mitochondrial DNA can impact the synthesis and function of MOTS-c, potentially influencing metabolic health.
How does MOTS-c influence metabolic homeostasis?
MOTS-c positively influences metabolic homeostasis by activating AMPK, which enhances glucose metabolism and insulin sensitivity, alongside regulating nuclear gene expression for improved metabolic balance. This highlights its potential role in promoting overall metabolic health.
What are the potential benefits of MOTS-c in insulin resistance research?
MOTS-c has the potential to significantly enhance insulin sensitivity in skeletal muscle and improve glucose metabolism, making it a promising candidate in the research and management of insulin resistance, diabetes, and metabolic syndrome.
Additionally, MOTS-c may also play a role in autoimmune diabetes by modulating immune cells and the immune response. Research suggests that MOTS-c can help prevent pancreatic islet destruction by influencing T cells and other immune cells involved in the autoimmune process.
Can MOTS-c have an impact on obesity?
MOTS-c does have a significant impact on obesity, as research suggests it can prevent diet-induced insulin resistance, reduce body weight, and improve glucose utilization and energy expenditure. Consequently, it holds potential as a therapeutic approach to combat obesity.
What are the future directions for MOTS-c research?
Future directions for MOTS-c research will involve unraveling its molecular mechanisms, evaluating its potential for treating metabolic diseases, and overcoming challenges like the unclear process of mRNA translocation from mitochondria.
References
- Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–54.
- Reynolds JC, Lai RW, Woodhead JST, Joly JH, Mitchell CJ, Cameron-Smith D, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470.
- Wan W, Zhang L, Lin Y, Rao X, Hua F, Ying J. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. J Transl Med. 2023;21(1):36.
- Kim SJ, Xiao J, Wan J, Cohen P, Yen K. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595(21):6613–21.
- Lu H, Wei M, Zhai Y, Li Q, Ye Z, Wang L, et al. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. J Mol Med. 2019;97(4):473–85.
- Yin X, Jing Y, Chen Q, Abbas AB, Hu J, Xu H. The intraperitoneal administration of MOTS-c produces antinociceptive and anti-inflammatory effects through the activation of AMPK pathway in the mouse formalin test. Eur J Pharmacol. 2020;870:172909.
- Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab. 2018;28(3):516–24.
- Kong BS, Min SH, Lee C, Cho YM. Mitochondrial-encoded MOTS-c prevents pancreatic islet destruction in autoimmune diabetes. Cell Rep. 2021;36(4):109447.
- Lu H, Tang S, Xue C, Liu Y, Wang J, Zhang W, et al. Mitochondrial-derived peptide MOTS-c increases adipose thermogenic activation to promote cold adaptation. Int J Mol Sci. 2019;20(10):2456.
- Ramanjaneya M, Jerobin J, Bettahi I, Bensila M, Aye M, Siveen KS, et al. Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects. Clin Endocrinol (Oxf). 2019;91(2):278–87.
- Kim SJ, Miller B, Kumagai H, Mehta HH, Xiang W, Liu J, et al. Peptides derived from small mitochondrial open reading frames: Genomic, biological, and therapeutic implications. Exp Cell Res. 2020;393(2):112056.
- Zempo H, Kim SJ, Fuku N, Nishida Y, Higaki Y, Wan J, et al. A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide MOTS-c. Aging (Albany NY). 2021;13(2):1692–717.
- Li S, Wang M, Ma J, Pang X, Yuan J, Pan Y, et al. MOTS-c and exercise restore cardiac function by activating NRG1-ErbB signaling in diabetic rats. Front Endocrinol (Lausanne). 2022;13:812032.
- Yin Y, Pan Y, He J, Zhong H, Wu Y, Ji C, et al. The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus. Pharmacol Res. 2022;175:105987.
- Knoop A, Thomas A, Thevis M. Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes. Rapid Commun Mass Spectrom. 2019;33(4):371–80.
- Fuku N, Pareja-Galeano H, Zempo H, Alis R, Arai Y, Lucia A, et al. The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. 2015;14(6):921–3.
- Lu H, Tang S, Xue C, Liu Y, Wang J, Zhang W, et al. Mitochondrial-derived peptide MOTS-c increases adipose thermogenic activation to promote cold adaptation. Int J Mol Sci. 2019;20(10):2456.
- Li Q, Lu H, Hu G, Ye Z, Zhai D, Yan Z, et al. Earlier changes in mice after D-galactose treatment were improved by mitochondria derived small peptide MOTS-c. Biochem Biophys Res Commun. 2019;513(2):439–45.
- Kim SJ, Xiao J, Wan J, Cohen P, Yen K. The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity. Physiol Rep. 2019;7(13):e14171.
- Reynolds JC, Lai RW, Woodhead JST, Joly JH, Mitchell CJ, Cameron-Smith D, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470.